See the DrugPatentWatch profile for Rilpivirine
When does rilpivirine HCl’s patent expire?
The exact expiration date depends on which specific patents (compound, formulations, or process) cover the rilpivirine HCl product in a given country and on the legal “type” of protection involved (patent term vs. any regulatory exclusivity). The information provided here does not include any patent or jurisdiction details, so the precise expiry date can’t be stated from the available data.
What patents typically control rilpivirine HCl products?
Rilpivirine HCl drug coverage is usually determined by one or more layers of protection, such as:
- Patents on the drug substance (compound patents).
- Patents on specific formulations (e.g., tablet compositions) or manufacturing processes.
- Country-specific extensions, if any, and patent-term adjustments.
- Regulatory exclusivities that may delay generic entry even after patent expiry.
Which one governs “expiry” will vary by market, because different jurisdictions rely on different patent filings and enforcement histories.
How do you find the real expiry date for a specific country and brand?
To get the correct expiry for “rilpivirine HCl,” you typically need:
- The drug’s marketed name (brand) and dosage form (e.g., tablets).
- The country/market (US, EU, UK, etc.).
- The relevant patent family/patent numbers listed in that market’s regulatory documentation or patent registers.
Then you check:
- The patent’s filing/grant dates and any adjustments that affect term.
- Whether exclusivity periods (regulatory data/market exclusivity) apply after patent expiry.
Can generics enter before patent expiry?
Often they can’t commercially launch until the relevant patents or exclusivities expire (or are invalidated/overcome through litigation or patent challenges). Even when a patent expires, regulatory exclusivity can still block marketing in some jurisdictions until its end.
What to check if you’re doing research or planning a launch
If you’re trying to determine when competitors can market rilpivirine HCl, focus on:
- The specific jurisdiction’s patent register for the rilpivirine HCl product.
- Any court rulings or settlements tied to that patent family.
- Market authorization documents that reference the protecting patents.
Quick next step
If you tell me the country (for example, US or EU) and the brand/dosage form you mean (e.g., rilpivirine HCl tablets for HIV therapy), I can narrow down what expiry date you’re likely looking for and what type of protection is expected to control it.